Clinical Trials Directory

Trials / Unknown

UnknownNCT03117608

A Single Intra-articular Injection of aMAT vs PRP in Patients With OA of the Knee

A SINGLE-BLIND, RANDOMIZED, CONTROLLED STUDY OF A SINGLE, INTRA-ARTICULAR INJECTION OF AUTOLOGOUS MICRO-FRAGMENTED ADIPOSE TISSUE (aMAT) VERSUS (VS) PRP IN PATIENTS WITH OSTEOARTHRITIS (OA) OF THE KNEE

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
118 (estimated)
Sponsor
Lipogems International spa · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The study proposes to compare performances and safety of intra-articular injections of aMAT with those of a control group (PRP injections) for the treatment of symptomatic OA of the knee. The end-points will be determined evaluating the performances of the treatment group in terms of improvement of the symptomatology, functional recovery and radiological appearance.

Detailed description

The clinical trial is a prospective, randomized, controlled, two-arm, single-blind study, involving 118 patients affected by symptomatic OA of the knee joint. Eligible subjects will be randomly allocated to one of the two treatment groups, with a 1:1 randomization ratio. Respectively, 59 patients treated with a single intra-articular injection of aMAT, and 59 patients treated with a single intra-articular injection of PRP. The patients enrolled in the study will be treated according to the study protocol and followed after treatment with periodic visits and diagnostic imaging examinations, as Magnetic Resonance Imaging at twelve and twenty-four months follow-up and X-Ray, at three, six, twelve, and twenty-four months of follow-up.

Conditions

Interventions

TypeNameDescription
BIOLOGICALinjection of autologous micro-fragmented adipose tissue (aMAT)adipose tissue will be obtained from abdominal region or buttocks and aMAT, and processed with Lipogems® technology.
BIOLOGICALinjection of Platelet-rich Plasma (PRP)injection of platelet-rich plasma

Timeline

Start date
2017-02-24
Primary completion
2022-08-24
Completion
2024-02-24
First posted
2017-04-18
Last updated
2017-08-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03117608. Inclusion in this directory is not an endorsement.